From the National Data Bank for Rheumatic Diseases; University of Kansas School of Medicine, Wichita, Kansas; US National Institute of Nursing Research, National Institutes of Health (NIH), Bethesda, Maryland, USA; Faculty of Behavioral Management and Social Sciences, Psychology, Health and Technology, University of Twente, Enschede, the Netherlands; Department of Internal Medicine 1, Klinikum Saarbrücken, Saarbrücken; Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany.
F. Wolfe, MD, National Data Bank for Rheumatic Diseases, Wichita, and University of Kansas School of Medicine; B. Walitt, MD, PhD, National Institute of Nursing Research, NIH; J.J. Rasker, MD, Faculty of Behavioral Management and Social Sciences, Psychology, Health and Technology, University of Twente; W. Häuser, MD, Department of Internal Medicine 1, Klinikum Saarbrücken, and Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München.
J Rheumatol. 2019 Feb;46(2):204-212. doi: 10.3899/jrheum.180083. Epub 2018 Jul 15.
Polysymptomatic distress (PSD) is the underlying metric of fibromyalgia (FM), and levels of PSD can identify criteria-positive FM with > 90% accuracy. We used levels of the PSD scale to test whether symptom levels in primary FM (PFM) and secondary FM (SFM) were the same and whether symptoms were equivalent in persons not meeting FM criteria.
We studied 1525 patients with a clinical diagnosis of FM and 12,037 patients with rheumatoid arthritis (RA). We used regression models to compare patients with potential and actual PFM to RA patients with potential and actual SFM for 17 key clinical variables.
When controlled for PSD values, the widespread pain index, symptom severity scale, and pain, global, quality of life, and physical and mental component scores were essentially the same or only slightly different in PFM and SFM. Health Assessment Questionnaire-Disability Index scores were slightly higher in SFM (0.21 units), as was the painful joint count (1.6 joints). Overall, higher PSD scores were associated with more severe symptoms or abnormal status. PSD scores in patients not satisfying FM criteria and in patients satisfying criteria operated similarly.
PFM and SFM are equivalent regarding symptom burden. PSD scores are more informative about severity and severity within diagnosis than dichotomization into FM/non-FM. Studies of FM versus "healthy individuals," or FM versus other diseases, are inherently defective, while studies of FM and PSD in RA offer the opportunity to have meaningful comparison groups, because there are no readily available unbiased appropriate controls for PFM.
多症状困扰(PSD)是纤维肌痛(FM)的潜在指标,PSD 水平可以以 >90%的准确率识别符合 FM 标准的患者。我们使用 PSD 量表的水平来检验原发性纤维肌痛(PFM)和继发性纤维肌痛(SFM)中的症状水平是否相同,以及不符合 FM 标准的人群中的症状是否相同。
我们研究了 1525 名临床诊断为 FM 的患者和 12037 名类风湿关节炎(RA)患者。我们使用回归模型比较了有潜在和实际 PFM 的患者与有潜在和实际 SFM 的 RA 患者在 17 个关键临床变量方面的情况。
在控制 PSD 值的情况下,广泛疼痛指数、症状严重程度量表、疼痛、整体、生活质量以及身体和心理成分评分在 PFM 和 SFM 中基本相同或仅有轻微差异。SFM 中的健康评估问卷残疾指数评分(0.21 分)略高,疼痛关节数(1.6 个关节)也略高。总体而言,PSD 评分越高,症状越严重或状态越异常。不符合 FM 标准的患者和符合标准的患者的 PSD 评分表现相似。
PFM 和 SFM 在症状负担方面是等效的。PSD 评分比将其分为 FM/非 FM 更能提供有关严重程度和诊断内严重程度的信息。FM 与“健康个体”或 FM 与其他疾病的比较研究存在固有缺陷,而 RA 中 FM 和 PSD 的研究提供了有意义的比较组的机会,因为没有现成的、无偏见的、合适的 PFM 对照。